ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.

GlaxoSmithKline · 2007
ClinicalTrials.gov · Datasets · License: Public Domain · 2007
Open Source ↗
breastneoplasms
neoplasms, breast, erbb2 overexpressing, erbb2 positive, lapatinib, invasive breast cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 915934
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.